Cargando…

MMP-9 Inhibition: a Therapeutic Strategy in Ischemic Stroke

Ischemic stroke is a leading cause of disability worldwide. In cerebral ischemia there is an enhanced expression of matrix metallo-proteinase-9 (MMP-9), which has been associated with various complications including excitotoxicity, neuronal damage, apoptosis, blood–brain barrier (BBB) opening leadin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaturvedi, Mayank, Kaczmarek, Leszek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918117/ https://www.ncbi.nlm.nih.gov/pubmed/24026771 http://dx.doi.org/10.1007/s12035-013-8538-z

Ejemplares similares

MMP-9 Contributes to Dendritic Spine Remodeling Following Traumatic Brain Injury
por: Pijet, Barbara, et al.
Publicado: (2019)

MMP9 SNP and MMP SNP–SNP interactions increase the risk for ischemic stroke in the Han Hakka population
por: Fan, Daofeng, et al.
Publicado: (2022)

Matrix metalloproteinase 9 (MMP-9) is indispensable for long term potentiation in the central and basal but not in the lateral nucleus of the amygdala
por: Gorkiewicz, Tomasz, et al.
Publicado: (2015)

Combined Effects of MMP-7, MMP-8 and MMP-26 on the Risk of Ischemic Stroke
por: Hsieh, Fang-I, et al.
Publicado: (2019)

Psychosocial Stress Induces Schizophrenia-Like Behavior in Mice With Reduced MMP-9 Activity
por: Vafadari, Behnam, et al.
Publicado: (2019)

The roles of MMP8/MMP10 polymorphisms in ischemic stroke susceptibility
por: Zhao, Yong, et al.
Publicado: (2022)

A potential relationship between MMP-9 rs2250889 and ischemic stroke susceptibility
por: Ge, Hanming, et al.
Publicado: (2023)

Association of the MMP-9 polymorphism and ischemic stroke risk in southern Chinese Han population
por: Gao, Ning, et al.
Publicado: (2019)

Elevation of MMP-9 Levels Promotes Epileptogenesis After Traumatic Brain Injury
por: Pijet, Barbara, et al.
Publicado: (2018)

Longitudinal Changes in BDNF and MMP-9 Protein Plasma Levels in Children after Cochlear Implantation
por: Matusiak, Monika, et al.
Publicado: (2023)

Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic Stroke
por: Turner, Renée J., et al.
Publicado: (2016)

Correlation Between MMP9 Promoter Methylation and Transient Ischemic Attack/Mild Ischemic Stroke with Early Cognitive Impairment
por: Miao, Meng, et al.
Publicado: (2023)

GSK-3β and MMP-9 Cooperate in the Control of Dendritic Spine Morphology
por: Kondratiuk, Ilona, et al.
Publicado: (2016)

MMP-9, a Potential Target for Cerebral Ischemic Treatment
por: Dong, Xue, et al.
Publicado: (2009)

Association between Increased Matrix Metalloproteinase-9 (MMP-9) Levels with Hyperglycaemia Incidence in Acute Ischemic Stroke Patients
por: Setyopranoto, Ismail, et al.
Publicado: (2018)

The Role of MMP-9 and MMP-9 Inhibition in Different Types of Thyroid Carcinoma
por: Li, Zhenshengnan, et al.
Publicado: (2023)

MMP-9 plasma level as biomarker of cochlear implantation outcome in cohort study of deaf children
por: Matusiak, Monika, et al.
Publicado: (2023)

Inhibition of MMP-2 and MMP-9 Activities by Limonium tetragonum Extract
por: Bae, Min-Joo, et al.
Publicado: (2016)

Connectivity map identifies luteolin as a treatment option of ischemic stroke by inhibiting MMP9 and activation of the PI3K/Akt signaling pathway
por: Luo, Shijian, et al.
Publicado: (2019)

Meta-analysis of matrix metalloproteinase (MMP)-9 C1562T polymorphism and susceptibility to ischemic stroke in the Chinese population
por: Jiang, Yan, et al.
Publicado: (2020)

Neuronal Death Mechanisms and Therapeutic Strategy in Ischemic Stroke
por: Mao, Rui, et al.
Publicado: (2022)

Editorial: Inflammation in ischemic stroke and novel therapeutic strategies for stroke treatment
por: Marei, Hany E., et al.
Publicado: (2022)

Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood–brain barrier
por: Chaturvedi, Mayank, et al.
Publicado: (2014)

Matrix Metalloproteinase-9 (MMP-9) Gene Polymorphism in Stroke Patients
por: Buraczynska, Kinga, et al.
Publicado: (2015)

Simultaneous targeting of CD44 and MMP9 catalytic and hemopexin domains as a therapeutic strategy
por: Yosef, Gal, et al.
Publicado: (2021)

Curcumin prevents reperfusion injury following ischemic stroke in rats via inhibition of NF-κB, ICAM-1, MMP-9 and caspase-3 expression
por: Li, Wei, et al.
Publicado: (2017)

Novel Therapeutic Strategies for Ischemic Stroke: Recent Insights into Autophagy
por: Lu, Xiaocheng, et al.
Publicado: (2022)

Prospective cohort study reveals MMP-9, a neuroplasticity regulator, as a prediction marker of cochlear implantation outcome in prelingual deafness treatment
por: Matusiak, Monika, et al.
Publicado: (2022)

A normal genetic variation modulates synaptic MMP‐9 protein levels and the severity of schizophrenia symptoms
por: Lepeta, Katarzyna, et al.
Publicado: (2017)

Functional Polymorphism of MMP9 and BDNF as Potential Biomarker of Auditory Neuroplasticity in Prelingual Deafness Treatment With Cochlear Implantation—A Retrospective Cohort Analysis
por: Matusiak, Monika, et al.
Publicado: (2021)

The Role of Sirt1 in Ischemic Stroke: Pathogenesis and Therapeutic Strategies
por: Zhang, Jun-Fang, et al.
Publicado: (2018)

Microglial Polarization: Novel Therapeutic Strategy against Ischemic Stroke
por: Xue, Yimeng, et al.
Publicado: (2021)

Role for MMP-9 in stress-induced downregulation of nectin-3 in hippocampal CA1 and associated behavioural alterations
por: van der Kooij, Michael A., et al.
Publicado: (2014)

LOX inhibition downregulates MMP-2 and MMP-9 in gastric cancer tissues and cells
por: Zhao, Lei, et al.
Publicado: (2019)

Dental-Pulp Stem Cells as a Therapeutic Strategy for Ischemic Stroke
por: Nito, Chikako, et al.
Publicado: (2022)

MMP-9 as a Biomarker for Predicting Hemorrhagic Strokes in Moyamoya Disease
por: Lu, Junlin, et al.
Publicado: (2021)

Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma
por: Webb, Anderson H., et al.
Publicado: (2017)

Diosmetin inhibits the metastasis of hepatocellular carcinoma cells by downregulating the expression levels of MMP-2 and MMP-9
por: LIU, JIE, et al.
Publicado: (2016)

Lupinus albus Protein Components Inhibit MMP-2 and MMP-9 Gelatinolytic Activity In Vitro and In Vivo
por: Mota, Joana, et al.
Publicado: (2021)

Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
por: Moroz, Andrei, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5inhgfvuq2k5859ilal0bv86tu